tradingkey.logo
tradingkey.logo
Search

Briacell Therapeutics Corp

BCTX
Add to Watchlist
3.950USD
+0.680+20.80%
Close 11-06 16:00(ET)
34.37MMarket Cap
LossP/E TTM

BCTX Financials

See Briacell Therapeutics Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
34.37M
Dividend TTM
0.00
P/E TTM
-0.28
EPS TTM
-14.41
Revenue
--
Net Profit
-26.31M
ROE
-171.72%
ROA
-139.50%
Briacell Therapeutics Corp Earnings Date
Latest Release
Jun 9, 2026
EPS / Forecast
-0.99/-2.74
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
83.74%-1.50
39.75%-0.99
-10.58%-2.58
-33.20%-4.35
-805.38%-9.23
-201.85%-1.64
78.02%-2.33
-158.00%-3.27
55.27%-1.02
134.03%1.61
7.70%-10.60
626.62%5.63
---2.28
---4.73
---11.49
---1.07
----
----
----
----
Net Profit
-52.27%-12.32M
-16.94%-7.16M
-14.79%-7.22M
-41.28%-8.20M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.80M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6.00M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
Operating profit
-47.05%-12.58M
-20.42%-7.62M
-5.05%-7.53M
-61.52%-8.32M
-48.31%-8.55M
31.44%-6.33M
27.06%-7.17M
39.40%-5.15M
25.15%-5.77M
-62.58%-9.23M
-119.10%-9.83M
-57.37%-8.50M
-47.22%-7.71M
-37.68%-5.68M
-23.02%-4.49M
-136.48%-5.40M
---5.23M
14.22%-4.12M
-1817.90%-3.65M
-500.68%-2.28M
Net Profit
-52.27%-12.32M
-16.94%-7.16M
-14.79%-7.22M
-41.28%-8.20M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.80M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6.00M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
Current assets
10.63%22.04M
71.75%25.39M
349.26%32.18M
38.07%11.35M
445.36%19.93M
167.36%14.79M
-39.00%7.16M
-55.35%8.22M
-86.44%3.65M
-81.26%5.53M
-65.40%11.74M
-51.84%18.41M
-36.36%26.95M
-36.18%29.50M
-29.76%33.94M
-31.64%38.22M
-26.73%42.35M
122.47%46.23M
22457.46%48.32M
25793.72%55.92M
Total current liabilities
100.65%7.98M
-17.09%3.59M
-39.10%3.19M
-33.49%3.32M
-46.68%3.98M
-35.92%4.33M
33.29%5.23M
376.69%4.99M
314.17%7.46M
388.60%6.76M
485.36%3.92M
7.44%1.05M
91.42%1.80M
277.59%1.38M
10.78%670.41K
125.81%974.05K
69.02%941.09K
115.84%366.29K
-84.28%605.15K
-88.28%431.37K
Total assets
8.91%23.58M
59.23%27.07M
258.78%33.59M
25.55%13.08M
268.68%21.65M
174.08%17.00M
-23.44%9.36M
-44.07%10.41M
-78.38%5.87M
-79.13%6.20M
-64.20%12.23M
-51.58%18.62M
-36.20%27.16M
-36.03%29.72M
-29.64%34.16M
-31.53%38.45M
-26.65%42.58M
120.94%46.46M
10508.72%48.55M
12294.77%56.16M
Total liabilities
85.85%8.02M
-27.63%3.66M
-44.91%3.38M
-44.42%3.72M
-49.57%4.32M
-59.31%5.06M
-70.14%6.14M
-58.38%6.70M
-72.34%8.56M
-65.08%12.44M
-42.02%20.55M
-42.73%16.10M
-4.05%30.94M
-2.43%35.61M
10.31%35.44M
-48.48%28.12M
6.18%32.25M
405.38%36.50M
703.30%32.13M
1327.22%54.57M
Total equity
-10.24%15.56M
96.04%23.41M
836.31%30.21M
151.83%9.35M
745.60%17.33M
291.58%11.94M
138.80%3.23M
47.56%3.71M
28.92%-2.68M
-5.78%-6.23M
-549.50%-8.32M
-75.65%2.52M
-136.57%-3.78M
-159.17%-5.89M
-107.80%-1.28M
552.51%10.33M
-62.67%10.33M
-27.87%9.96M
563.77%16.43M
146.99%1.58M
Net operating income
26.73%-5.96M
1.99%-7.02M
-34.58%-7.97M
-10.78%-7.70M
-101.51%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.40M
-114.69%-7.61M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
---3.33M
13.67%-4.82M
-1515.54%-2.56M
-2961.48%-1.78M
Net investment
167.52%4.99M
-15141.00%-16.00M
9809.96%7.28M
0.00%-75.00K
-1517.99%-7.39M
53.33%-105.00K
---75.00K
---75.00K
---456.80K
---225.00K
----
----
----
----
----
----
----
----
----
----
Net financing
-70.93%3.94M
-100.00%0.00
434.34%27.87M
-100.00%0.00
206.79%13.56M
--14.71M
--5.22M
--11.96M
10.47%4.42M
----
--0.00
100.00%0.00
2603.40%4.00M
-99.88%1.59K
100.00%0.00
---47.29K
---159.78K
-94.83%1.37M
-2407.48%-4.95M
-100.00%0.00

FAQs

What are the current assets of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its current assets were 22.04M, with a year-on-year change of 10.63.

What are the total assets of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its total assets of Briacell Therapeutics Corp were 23.58M, with a year-on-year change of 8.91.

What are the total liabilities of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its total liabilities of Briacell Therapeutics Corp were 8.02M, with a year-on-year change of 85.85.

What is the total equity of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its total equity of Briacell Therapeutics Corp was 15.56M, with a year-on-year change of -10.24.

What is the net operating income of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its net operating income of Briacell Therapeutics Corp was -36.05M, with a year-on-year change of -32.53.

What is the net investment of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its net investment of Briacell Therapeutics Corp was -3.81M, with a year-on-year change of 50.23.

What is the net financing of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its net financing of Briacell Therapeutics Corp was 31.81M, with a year-on-year change of -30.00.

What is the Earnings Per Share (EPS) of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its Earnings Per Share (EPS) was -6.97, with a year-on-year change of 88.80.

What is the net income of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its net income was -34.90M, with a year-on-year change of -32.66.

What is the Return on Equity (ROE) of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its Return on Equity (ROE) was -203.63, with a year-on-year change of 40.03.

What is the Return on Assets (ROA) of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its Return on Assets (ROA) was -156.20, with a year-on-year change of 19.06.

What is the operating profit of Briacell Therapeutics Corp?

According to Briacell Therapeutics Corp's FY2026 earnings report, its operating profit was -36.05M, with a year-on-year change of -32.53.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.